ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

32696 results sorted by trial registration date.
  • Clinical efficacy of Moxifloxacin in the treatment of Bacterial Keratitis: A Randomised Clinical Trial

    To determine the clinical efficacy and safety of moxifloxacin (1.0%) in patients treated with bacterial keratitis compared with patients treated with ofloxacin (0.3%) or fortified tobramycin (1.33%)/cephazolin (5%).

  • Atorvastatin for Renal Protection After Cardiopulmonary Bypass

  • A randomised placebo-controlled trial of testosterone undecanoate in obese men as adjuvant therapy for a weight loss program

    This is a randomised placebo-controlled trial of testosterone undecanoate in obese men with obstructive slee apena as adjunctive therapy for a weight loss programme. The aim of the study is to evaluate the additional effect of testosterone replacement on weight loss and motivation in obese (BMI>30kg/m2) men with obstructive sleep apnea undergoing a weight reduction program. The primary endopint is weight loss after 4.5 months with other secondary endpoints including body composition, anthropometry, physical activity, metabolic markers (eg insulin sensitivity, basal metabolic rate) and blood hormone concentrations.

  • Investigation of AV411 in neuropathic pain

  • Group Cognitive Behavioural Therapy (CBT) and Mindfulness-Based Cognitive Therapy (MBCT) for depression

    This study aims to examine the effectiveness of group Mindfulness-Based Cognitive Therapy (MBCT) and standard Cognitive Behavioural Therapy (CBT) as treatments for depression as well as examine the mechanisms of change and predictors of change in both groups. Depressed participants will be recruited and randomly assigned to receive one of the group programs. Both programs will run for 2.5 hours a week for eight weeks. Participants will receive a clinical assessment prior to randomisation and will complete a number of questionnaires before and after the group program and at follow-up assessments at 6 and 12 months. The first pilot phase of the study will assess feasibility and likely effectiveness of MBCT, and pending results will be followed by the second main phase of the study.

  • Improving childhood asthma management through a telemedicine monitoring network

    This project will assess and optimise the use of telemedicine for asthma management in children and young people across the severity range of asthma to regularly provide asthma education, provide appropriate strategies for asthma management based on the asthma management plan and reminders to take regular medication if prescribed. The use of telephone/SMS technology is highly acceptable to young people and families generally and is readily available across most patient groups.

  • The effectiveness of the Resilient Families school-based parent education program in promoting adolescent health

    The primary purpose of the Resilient Families intervention is to help students and parents develop knowledge, skills, and support networks to promote adolescent health and wellbeing during the early years of secondary school. The main hypothesis is that students in the Resilient Families schools will show improvements in family relationships and reductions in depression, substance use and antisocial behaviour relative to the control school students.

  • Modified Starch and Colon Health Study 2006

    The objective of this study is to determine whether bacteria in the colon of humans can release butyrate bound to starch. This will be investigated by feeding a modified test starch to volunteers and measuring butyrate levels in faeces, the effects on the bacteria and other bowel health indicators.

  • Sleep Health in Tetraplegia-A population survey and home monitoring of sleep disordered breathing

    Spinal cord injury (SCI) is one of the most catastrophic disabilities to afflict man. The paralysis is permanent and the disability severe. There is emerging, compelling evidence that tetraplegia, the loss of function in both arms and legs, results in greater secondary disability due to disturbed sleep and breathing overnight. This study aims to comprehensively evaluate sleep health in tetraplegia by documenting sleep disturbances and determining the prevalence and nature of any sleep disordered breathing (SDB) in the Victorian population with tetraplegia. Over 18 months we propose to gain questionnaire responses from people with tetraplegia in Victoria regarding the frequency, nature and severity of any sleep disturbances they may experience. Additionally, we will perform full sleep studies at home on those with more severe injuries. The project will produce a comprehensive description of the tetraplegic population in Victoria, it will identify the nature and prevalence of sleep disturbances in this population, it will characterise sleep quality and will establish the prevalence of Obstructive Sleep Apnoea (OSA) and other forms of SDB in this group. It is known that OSA and sleep disturbances are significantly under diagnosed in people with SCI and this project is likely have an immediate, positive impact for the participants as problems are diagnosed and treatments offered. Any reduction in disability will have immediate benefits for the individuals involved and will reduce the cost to the community for these profoundly disabled people.

  • Hepatitis B immunity and response to a booster dose of hepatitis B vaccine in Indigenous children who recieved hepatitis B vaccines in infancy

    Adolescent enrolled in the Aboriginal Birth Cohort Study will have their serology to hepatitis B measured. Adolescents who received hepatitis B vaccines in infancy and have low immunity will be offered booster doses of the vaccine and have their immunity measured 2-4 weeks post vaccination.

Tags:
  • Finding clinical trials